Sabnis N - Search Results

1

Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy.

Raut S, Mooberry L, Sabnis N, Garud A, Dossou AS, Lacko A. Raut S, et al. Among authors: sabnis n. Front Pharmacol. 2018 Oct 15;9:1154. doi: 10.3389/fphar.2018.01154. eCollection 2018. Front Pharmacol. 2018. PMID: 30374303 Free PMC article. Review.

2

Studies on solvatochromic properties of aminophenylstyryl-quinolinum dye, LDS 798, and its application in studying submicron lipid based structure.

Sarkar P, Luchowski R, Raut S, Sabnis N, Remaley A, Lacko AG, Thamake S, Gryczynski Z, Gryczynski I. Sarkar P, et al. Among authors: sabnis n. Biophys Chem. 2010 Dec;153(1):61-9. doi: 10.1016/j.bpc.2010.10.005. Epub 2010 Oct 13. Biophys Chem. 2010. PMID: 21041016

3

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK. Shahzad MM, et al. Among authors: sabnis n. Neoplasia. 2011 Apr;13(4):309-19. doi: 10.1593/neo.101372. Neoplasia. 2011. PMID: 21472135 Free PMC article.

4

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles.

Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG. Sabnis N, et al. Int J Nanomedicine. 2012;7:975-83. doi: 10.2147/IJN.S28029. Epub 2012 Feb 22. Int J Nanomedicine. 2012. PMID: 22393294 Free PMC article.

5

Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.

Sabnis N, Lacko AG. Sabnis N, et al. Ther Deliv. 2012 May;3(5):599-608. doi: 10.4155/tde.12.41. Ther Deliv. 2012. PMID: 22834404 Review.

6

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics.

Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. Cruz PM, et al. Among authors: sabnis n. Front Pharmacol. 2013 Sep 25;4:119. doi: 10.3389/fphar.2013.00119. Front Pharmacol. 2013. PMID: 24093019 Free PMC article. Review.

7

The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.

Johnson R, Sabnis N, McConathy WJ, Lacko AG. Johnson R, et al. Among authors: sabnis n. Pharmaceutics. 2013;5(2):353-70. doi: 10.3390/pharmaceutics5020353. Pharmaceutics. 2013. PMID: 24244833 Free PMC article.

8

Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.

Sabnis N, Pratap S, Akopova I, Bowman PW, Lacko AG. Sabnis N, et al. Front Pediatr. 2013 Mar 21;1:6. doi: 10.3389/fped.2013.00006. eCollection 2013 Mar 21. Front Pediatr. 2013. PMID: 24459664 Free PMC article.

9

Targeted nanoparticles for pediatric leukemia therapy.

Basha R, Sabnis N, Heym K, Bowman WP, Lacko AG. Basha R, et al. Among authors: sabnis n. Front Oncol. 2014 May 13;4:101. doi: 10.3389/fonc.2014.00101. eCollection 2014. Front Oncol. 2014. PMID: 24860784 Free PMC article. Review.

10

A homodimeric BODIPY rotor as a fluorescent viscosity sensor for membrane-mimicking and cellular environments.

Raut S, Kimball J, Fudala R, Doan H, Maliwal B, Sabnis N, Lacko A, Gryczynski I, Dzyuba SV, Gryczynski Z. Raut S, et al. Among authors: sabnis n. Phys Chem Chem Phys. 2014 Dec 28;16(48):27037-42. doi: 10.1039/c4cp04260c. Phys Chem Chem Phys. 2014. PMID: 25381865 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page